GUGGENHEIM CAPITAL LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2018$2,429,000
-16.2%
52,980
+8.1%
0.02%
-15.8%
Q2 2018$2,897,000
+2.6%
48,989
+18.1%
0.02%
+171.4%
Q1 2018$2,823,000
-20.9%
41,484
+14.8%
0.01%
-12.5%
Q4 2017$3,571,000
-29.7%
36,125
-14.9%
0.01%
-33.3%
Q3 2017$5,083,000
+26.6%
42,449
-7.6%
0.01%
+9.1%
Q2 2017$4,016,000
+86.3%
45,950
-20.7%
0.01%
+83.3%
Q1 2017$2,156,000
+21.7%
57,981
+0.4%
0.01%
+20.0%
Q4 2016$1,772,000
-49.1%
57,731
+11.1%
0.01%
-54.5%
Q3 2016$3,483,000
+912.5%
51,947
+349.6%
0.01%
+1000.0%
Q2 2016$344,000
-83.0%
11,555
-83.2%
0.00%
-83.3%
Q1 2016$2,025,000
-51.9%
68,932
+28.3%
0.01%
-50.0%
Q4 2015$4,211,000
+39.1%
53,715
+33.7%
0.01%
+33.3%
Q3 2015$3,028,000
-71.9%
40,187
-56.4%
0.01%
-66.7%
Q2 2015$10,767,000
-4.9%
92,225
+92.3%
0.03%0.0%
Q1 2015$11,326,000
+27.4%
47,970
+2.1%
0.03%
+22.7%
Q4 2014$8,891,000
+10.8%
46,973
+39.7%
0.02%
+15.8%
Q3 2014$8,022,000
+78.9%
33,625
-50.5%
0.02%
+72.7%
Q2 2014$4,483,000
-28.1%
67,921
+13.5%
0.01%
-38.9%
Q1 2014$6,234,000
+28.5%
59,860
+27.8%
0.02%
+20.0%
Q4 2013$4,850,00046,8440.02%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2015
NameSharesValueWeighting ↓
HARVARD MANAGEMENT CO INC 600,000$45,216,0003.56%
Avalon Global Asset Management LLC 32,900$2,479,0001.79%
CORNERSTONE CAPITAL MANAGEMENT LLC 495,145$37,314,0001.58%
BB BIOTECH AG 521,991$39,337,0001.25%
WEATHERBIE CAPITAL, LLC 137,041$10,327,0001.20%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$428,527,0001.19%
TOBAM 318,384$23,994,0000.94%
Orbimed Advisors 1,195,500$90,093,0000.91%
Capital International Sarl 109,405$8,245,0000.74%
CAPITAL INTERNATIONAL LTD /CA/ 145,697$10,980,0000.73%
View complete list of PUMA BIOTECHNOLOGY INC shareholders